← Leaderboards
Glenn Heller
Sloan-Kettering Institute For Cancer Res
$7,155,475
Attributed
$7,155,475
Total exposure
9
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $769K · FY2005–21$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$7,155,475 · 9
By mechanism
P01$3,991,373 · 4
P50$2,313,560 · 4
R01$850,542 · 1
Top collaborators
No co-investigators on record.
Most similar at Sloan-Kettering Institute For Cancer Res
Same institution · by research overlap
- Pier Paolo Pandolfi$54,825,346
- Neal Rosen$21,048,001
- Howard I Scher$6,446,552
- Carlos Cordon-Cardo$7,210,529
- William L Gerald$10,319,111
Others in their field
Top investigators on “Research Personnel”
- David Heimbrook · Leidos Biomedical Research, Inc.$701,463,488
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Leonard Freedman · Leidos Biomedical Research, Inc.$557,978,666
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David R. Weir · University Of Michigan At Ann Arbor$364,053,504
- Judith S. Currier · University Of California Los Angeles$284,675,012
Research focus
Research PersonnelMethodologyLaboratoriesDesignBaseClinical TrialsBiostatistics CoreSample SizeClinical ResearchExperimental DesignsPreclinical StudyProceduresRandomizedAreaData AnalysesMemberPrincipal InvestigatorClinical Trials DesignMemorial Sloan-Kettering Cancer CenterAnticancer ResearchProtocols DocumentationCollaborationsProgramsPrimary Outcome
Grant awards (35)
Core B: Biostatistics Core$66,672
P50 · FY2021 · CA · contact PI
Core B: Biostatistics Core$186,986
P50 · FY2020 · CA · contact PI
Inferential methods to assess the incremental value of new biomarkers in risk classification models$285,054
R01 · FY2019 · CA · contact PI
Core B: Biostatistics Core$186,138
P50 · FY2019 · CA · contact PI
Inferential methods to assess the incremental value of new biomarkers in risk classification models$282,744
R01 · FY2018 · CA · contact PI
Core B: Biostatistics Core$196,479
P50 · FY2018 · CA · contact PI
Inferential methods to assess the incremental value of new biomarkers in risk classification models$282,744
R01 · FY2017 · CA · contact PI
Core B: Biostatistics Core$196,117
P50 · FY2017 · CA · contact PI
Biostatistics Core$171,691
P01 · FY2017 · CA · contact PI
Biostatistics Core$204,226
P01 · FY2016 · CA · contact PI
Core B: Biostatistics Core$191,064
P50 · FY2016 · CA · contact PI
Biostatistics Core$204,226
P01 · FY2015 · CA · contact PI
BIOSTATISTICS CORE$164,005
P50 · FY2015 · CA · contact PI
Biostatistics Core$198,099
P01 · FY2014 · CA · contact PI
BIOSTATISTICS CORE$161,765
P50 · FY2014 · CA · contact PI
Biostatistics Core$204,227
P01 · FY2013 · CA · contact PI
BIOSTATISTICS CORE$158,548
P50 · FY2013 · CA · contact PI
BIOSTATISTICS CORE$171,024
P50 · FY2012 · CA · contact PI
BIOSTATISTICS CORE$234,142
P01 · FY2011 · CA · contact PI
BIOSTATISTICS CORE$185,925
P01 · FY2010 · CA · contact PI
BIOSTATISTICS CORE$134,915
P50 · FY2010 · CA · contact PI
Core C$451,769
P01 · FY2009 · CA · contact PI
BIOSTATISTICS CORE$182,870
P01 · FY2009 · CA · contact PI
BIOSTATISTICS CORE$133,473
P50 · FY2009 · CA · contact PI
Core C$439,027
P01 · FY2008 · CA · contact PI
BIOSTATISTICS CORE$177,742
P01 · FY2008 · CA · contact PI
BIOSTATISTICS CORE$152,213
P50 · FY2008 · CA · contact PI
Core C$435,390
P01 · FY2007 · CA · contact PI
BIOSTATISTICS CORE$162,723
P01 · FY2007 · CA · contact PI
BIOSTATISTICS CORE$148,394
P50 · FY2007 · CA · contact PI
Core C$250,568
P01 · FY2006 · CA · contact PI
BIOSTATISTICS CORE$65,767
P50 · FY2006 · CA · contact PI
Core C$243,532
P01 · FY2005 · CA
CORE--BIOSTATISTICS CORE$0
P01 · FY2001 · CA
CORE--BIOSTATISTICS CORE$245,216
P01 · FY2000 · CA